Sanofi (SAN), the French drugmaker that fired Chief Executive Officer Chris Viehbacher last month, said it may get 30 billion euros ($37.6 billion) in sales from new drugs it plans to introduce.
Sanofi may get approvals for as many as 18 products between 2014 and 2020, which cumulatively may generate more than 30 billion euros over the first five years of sales, the Paris-based company said in a statement today. Sanofi will be presenting more details on its drug development to analysts at a...
16:36 AT&T, Time Warner poised to lobby lawmakers, regulators on proposed $85-billion merger20
12:23 Lockheed Martin's quarterly profit handily beats estimates17
11:46 GM reports record 3Q earnings despite slowing US sales10
11:41 Caterpillar earnings: 85 cents per share, vs expected EPS of 76 cents18